 |
 |
|||||||||||||||||||
|
||||||||||||||||||||
 |
 |
Publications
|
Nuytemans K, Rademakers R, Theuns J, Pals P, Engelborghs S, Pickut B, de Pooter T, Peeters K, Mattheijssens M, Van den Broeck M, Cras P, De Deyn PP, van Broeckhoven C. Founder mutation p.R1441C in the leucine-rich repeat kinase 2 gene in Belgian Parkinson's disease patient. Eur J Hum Genet 16: 471-9, 2008 (PubMed ID: 18197194) |
|
|
LRRK2:
(Arg1325Gln)
(Arg1441Cys)
(Lys1468Glu)
(Arg1483Gln)
(Tyr2189Cys)
|
|
ID: 153 | |
|
Abdalla-Carvalho CB, Santos-Rebouças CB, Guimarães BC, Campos M, Pereira JS, Zuma de Rosso AL, Nicaretta DH, Marinho E Silva M, Mendonça Dos Santos J, Pimentel MM.. Genetic analysis of LRRK2 functional domains in Brazilian patients with Parkinson's disease. Eur J Neurol Epub: , 2010 (PubMed ID: 20443975) |
|
|
LRRK2:
(Arg1398)
(Thr1410Met)
(Gly2019Ser)
(Cys2139Ser)
(Tyr2189Cys)
|
|
ID: 425 | |
Mutation color legend:
Red: mutation is pathogenic
Orange: pathogenic nature is unclear
Green: mutation is not pathogenic
 |
Top | Back | PDmutDB Home |